Design and synthesis of novel 3-(benzo[d]oxazol-2-yl)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine derivatives as selective G-protein-coupled receptor kinase-2 and -5 inhibitors.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2013-12-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2013.10.036PMID 24210504
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Myocardial Ablation of G Protein–Coupled Receptor Kinase 2 (GRK2) Decreases Ischemia/Reperfusion Injury through an Anti-Intrinsic Apoptotic Pathway

  2013cited by this paper
• Myocardial G protein receptor-coupled kinase expression correlates with functional parameters and clinical severity in advanced heart failure.

  2012cited by this paper
• Synthesis and structure-activity relationship of aminopyridines with substituted benzoxazoles as c-Met kinase inhibitors.

  2012cited by this paper
• Paroxetine is a direct inhibitor of g protein-coupled receptor kinase 2 and increases myocardial contractility.

  2012cited by this paper
• Discovery of aminopyridines substituted with benzoxazole as orally active c-Met kinase inhibitors.

  2010cited by this paper
• The complex G protein‐coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets

  2010cited by this paper
• GRK mythology: G-protein receptor kinases in cardiovascular disease

  2009cited by this paper
• Myocardial Adeno-Associated Virus Serotype 6–&bgr;ARKct Gene Therapy Improves Cardiac Function and Normalizes the Neurohormonal Axis in Chronic Heart Failure

  2009cited by this paper
• Uncovering G protein-coupled receptor kinase-5 as a histone deacetylase kinase in the nucleus of cardiomyocytes

  2008cited by this paper
• G Protein-Coupled Receptor Kinase 2 Ablation in Cardiac Myocytes Before or After Myocardial Infarction Prevents Heart Failure

  2008cited by this paper
• Structures of Rhodopsin Kinase in Different Ligand States Reveal Key Elements Involved in G Protein-coupled Receptor Kinase Activation*

  2008cited by this paper
• Regulation of Receptor Tyrosine Kinase Signaling by GRKs and β-Arrestins

  2007cited by this paper
• Regulation of receptor tyrosine kinase signaling by GRKs and beta-arrestins.

  2007cited by this paper
• Regulation of receptor trafficking by GRKs and arrestins.

  2007cited by this paper
• The Structure of G Protein-coupled Receptor Kinase (GRK)-6 Defines a Second Lineage of GRKs*

  2006cited by this paper
• GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling.

  2006cited by this paper
• GRKs and β-arrestins: roles in receptor silencing, trafficking and signaling

  2006cited by this paper
• Pathophysiological roles of G-protein-coupled receptor kinases.

  2005cited by this paper
• A Predicted Amphipathic Helix Mediates Plasma Membrane Localization of GRK5*

  2004cited by this paper
• Differential functional expression of human myocardial G protein receptor kinases in left ventricular cardiac diseases.

  2004cited by this paper
• Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins.

  2002cited by this paper
• Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides†

  2001cited by this paper
• Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling.

  2001cited by this paper
• Structure-Function Analysis of G Protein-coupled Receptor Kinase-5

  1998cited by this paper
• G protein-coupled receptor kinases.

  1998cited by this paper
• Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice.

  1998cited by this paper
• Simulation of activation free energies in molecular systems

  1996cited by this paper
• A second generation force field for the simulation of proteins

  1995cited by this paper
• Identification, purification, and characterization of GRK5, a member of the family of G protein-coupled receptor kinases.

  1994cited by this paper
• Cloning and expression of GRK5: a member of the G protein-coupled receptor kinase family.

  1993cited by this paper
• Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium.

  1990cited by this paper
• The surgically denervated, transplanted human heart.

  1990cited by this paper

• Type X RTKs: HGF (hepatocyte growth factor) receptor family in GtoPdb v.2025.3

  2025cites this paper
• High-throughput and intelligent design of potential GRK2 inhibitor candidates using deep learning and mathematical programming methods

  2025cites this paper
• Unveiling G-protein coupled receptor kinase-5 inhibitors for chronic degenerative diseases: Multilayered prioritization employing explainable machine learning-driven multi-class QSAR, ligand-based pharmacophore and free energy-inspired molecular simulation.

  2024cites this paper
• Targeting GRK2 and GRK5 for treating chronic degenerative diseases: Advances and future perspectives.

  2022cites this paper
• Selectivity mechanism of GRK2/5 inhibition through in silico investigation

  2022cites this paper
• Nucleobase-Functionalized Poly(alkylthiophene)s: One-Pot, Sequential Direct Arylation Polymerization and Deprotection, and Surface Modification for Oil–Water Separations

  2021cites this paper
• Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma.

  2021cites this paper
• Targeting G protein-coupled receptor kinases (GRKs) to G protein-coupled receptors.

  2021cites this paper
• Design and biological evaluation of 3-aryl-4-alkylpyrazol-5-amines based on the target fishing.

  2020cites this paper
• Ligand-free synthesis of 2-aminoarylbenzoxazoles via copper-catalyzed C N/C O coupling

  2020cites this paper
• G protein-coupled receptor kinases as therapeutic targets in the heart

  2019cites this paper
• Structure-Based Design of Selective, Covalent G Protein-Coupled Receptor Kinase 5 Inhibitors.

  2019cites this paper
• Copper-catalyzed synthesis of 2-aminopyridylbenzoxazoles via domino reactions of intermolecular N-arylation and intramolecular O-arylation

  2019cites this paper
• Utilizing a structure-based docking approach to develop potent G protein-coupled receptor kinase (GRK) 2 and 5 inhibitors.

  2018cites this paper
• Development, Synthesis, and Characterization of G Protein-Coupled Receptor Kinase Inhibitors Using Structure Based Drug Design for the Advancement of Heart Failure Therapeutics

  2017cites this paper
• G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitors: Current Trends and Future Perspectives.

  2016cites this paper
• Recent Advances in the Development of Pharmacologically Active Compounds that Contain a Benzoxazole Scaffold

  2015cites this paper
• Identification of a series of 3-(benzo(d)oxazol-2-yl)-5-(1- (piperidin-4-yl)-1H-pyrazol-4-yl) pyridin-2-amines, as a new class of G-protein-coupled receptor kinase 2 and 5 inhibitor

  2014cites this paper
• Identification and Structure–Function Analysis of Subfamily Selective G Protein-Coupled Receptor Kinase Inhibitors

  2014cites this paper
• Molecular Basis for Small Molecule Inhibition of G Protein-Coupled Receptor Kinases

  2014cites this paper
• Identification and Characterization of Amlexanox as a G Protein-Coupled Receptor Kinase 5 Inhibitor

  2014cites this paper